The University of Texas MD Anderson Cancer Center’s Michale E. Keeling Center for Comparative Medicine and Research will open its doors to the community from 3 p.m. to 7 p.m. Friday, April 21.
“We welcome our Central Texas neighbors to visit and learn about the important research that we do at the Keeling Center to improve medical care by increasing our understanding of human disease,” said Christian Abee, D.V.M., director of the...
The University of Texas MD Anderson Children’s Cancer Hospital joins Houston restaurants and businesses to host its second annual Prom Party...
The University of Texas MD Anderson Cancer Center Chair of Immunology Jim Allison, Ph.D., whose pivotal insight to attack cancer by treating...
Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may be able to avoid follow-up breast and lymph node, or axillary, surgery, according to new findings from researchers at The University of Texas MD Anderson Cancer Center. The study, published today in JAMA Surgery, identifies the exceptional responders who are at lowest risk for local metastases and thereby are candidates for less invasive...
The University of Texas MD Anderson Cancer Center and Lion Biotechnologies, Inc., a biotechnology company developing novel cancer immunotherapies...
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® Seminar to Midland, for the second time, 11:...
Oncora Medical, a precision radiation oncology software company, and The University of Texas MD Anderson Cancer Center, today announced a...
An Innovative Research Grant from Stand Up to Cancer will help a University of Texas MD Anderson Cancer Center physician scientist and her...